Truist Securities Upgrades Biomea Fusion to Buy, Maintains Price Target to $54

Benzinga · 09/27 14:06
Truist Securities analyst Srikripa Devarakonda upgrades Biomea Fusion (NASDAQ:BMEA) from Hold to Buy and maintains the price target from $54 to $54.